ClinicalTrials.govpublic full text
68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks
prostate cancer, 68ga-rm2, bombesin, grp-r, 68ga-prostate specific membrane antigen, psma, pet/ct, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 839420
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.